冠状动脉疾病患者的个体化管理
Individualized Management of Patients with Coronary Artery Disease.
作者信息
Bil Jacek
机构信息
Department of Invasive Cardiology, Centre of Postgraduate Medical Education, 02-507 Warsaw, Poland.
出版信息
J Pers Med. 2022 Jul 29;12(8):1243. doi: 10.3390/jpm12081243.
Abstract
We can characterize personalized medicine as a compilation of diagnostic and screening modalities to better manage individual patients, their diseases, or their predisposition toward various disorders [...].
摘要
我们可以将个性化医疗描述为一系列诊断和筛查方法的汇总，以便更好地管理个体患者、他们的疾病或他们对各种疾病的易感性[...]。
相似文献
1
Individualized Management of Patients with Coronary Artery Disease.冠状动脉疾病患者的个体化管理
J Pers Med. 2022 Jul 29;12(8):1243. doi: 10.3390/jpm12081243.
2
Personalized Management of Cardiovascular Disorders.心血管疾病的个体化管理。
Med Princ Pract. 2017;26(5):399-414. doi: 10.1159/000481403. Epub 2017 Sep 11.
3
How do We Manage Coronary Artery Disease in Patients with CKD and ESRD?我们如何管理患有慢性肾脏病和终末期肾病的患者的冠状动脉疾病？
Electrolyte Blood Press. 2014 Dec;12(2):41-54. doi: 10.5049/EBP.2014.12.2.41. Epub 2014 Dec 31.
4
Estimating personalized diagnostic rules depending on individualized characteristics.根据个体特征估计个性化诊断规则。
Stat Med. 2017 Mar 30;36(7):1099-1117. doi: 10.1002/sim.7182. Epub 2016 Dec 4.
5
Impact of individualized segmentation on diagnostic performance of quantitative positron emission tomography for haemodynamically significant coronary artery disease.个体化分割对定量正电子发射断层扫描诊断有血流动力学意义的冠状动脉疾病的影响。
Eur Heart J Cardiovasc Imaging. 2019 May 1;20(5):525-532. doi: 10.1093/ehjci/jey201.
6
Pharmacogenetics, pharmacogenomics and ayurgenomics for personalized medicine: a paradigm shift.用于个性化医疗的药物遗传学、药物基因组学和阿育吠陀基因组学：一场范式转变。
Indian J Pharm Sci. 2015 Mar-Apr;77(2):135-41. doi: 10.4103/0250-474x.156543.
7
Toward Personalized Medicine: Does Genetic Diagnosis of Pediatric Cardiomyopathy Influence Patient Management?迈向个性化医疗：儿童心肌病的基因诊断是否会影响患者管理？
Prog Pediatr Cardiol. 2015 Jul 1;39(1):43-47. doi: 10.1016/j.ppedcard.2015.01.008.
8
The faces of personalized medicine: a framework for understanding its meaning and scope.个性化医学的面貌：理解其含义和范围的框架。
Value Health. 2013 Sep-Oct;16(6 Suppl):S4-9. doi: 10.1016/j.jval.2013.06.005.
9
Utility of a genomic-based, personalized medicine test in patients presenting with symptoms suggesting coronary artery disease.用于疑似冠心病患者的基于基因组的个体化医学检测的效用。
J Am Board Fam Med. 2014 Mar-Apr;27(2):258-67. doi: 10.3122/jabfm.2014.02.130155.
10
Challenges and strategies in the management of coronary artery aneurysms.冠状动脉瘤管理中的挑战与策略
Hellenic J Cardiol. 2021 Mar-Apr;62(2):112-120. doi: 10.1016/j.hjc.2020.09.004. Epub 2020 Sep 13.
本文引用的文献
1
The Feasibility of Ultra-Sensitive Phonocardiography in Acute Chest Pain Patients of a Tertiary Care Emergency Department (ScorED Feasibility Study).三级护理急诊科急性胸痛患者超敏心音图检查的可行性（ScorED可行性研究）
J Pers Med. 2022 Apr 14;12(4):631. doi: 10.3390/jpm12040631.
2
Clinical Outcomes of Cardiac Rehabilitation in Women with Coronary Artery Disease-Differences in Comparison with Men.冠心病女性患者心脏康复的临床结局——与男性的比较差异
J Pers Med. 2022 Apr 8;12(4):600. doi: 10.3390/jpm12040600.
3
Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Myocardial Infarction in Patients with Atrial Fibrillation with or without Percutaneous Coronary Interventions: A Meta-Analysis.非维生素K拮抗剂口服抗凝药与伴或不伴经皮冠状动脉介入治疗的房颤患者心肌梗死风险：一项荟萃分析
J Pers Med. 2021 Oct 9;11(10):1013. doi: 10.3390/jpm11101013.
4
The Role of IL-6 and ET-1 in the Diagnosis of Coronary MicroVascular Disease in Women.白细胞介素-6和内皮素-1在女性冠状动脉微血管疾病诊断中的作用
J Pers Med. 2021 Sep 27;11(10):965. doi: 10.3390/jpm11100965.
5
Association of Kidney Disease, Potassium, and Cardiovascular Risk Factor Prevalence with Coronary Arteriosclerotic Burden, by Sex.按性别划分的肾脏疾病、钾与心血管危险因素患病率与冠状动脉粥样硬化负担的关联
J Pers Med. 2021 Jul 27;11(8):722. doi: 10.3390/jpm11080722.
6
What Can We Change in Diet and Behaviour in Order to Decrease Carotid Intima-Media Thickness in Patients with Obesity?为了降低肥胖患者的颈动脉内膜中层厚度，我们在饮食和行为方面可以做出哪些改变？
J Pers Med. 2021 Jun 3;11(6):505. doi: 10.3390/jpm11060505.
7
The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up.硬化素水平对接受冠状动脉造影患者长期预后的影响：一项为期9年随访的个性化研究
J Pers Med. 2021 Mar 6;11(3):186. doi: 10.3390/jpm11030186.
8
Serum Ceramides as Prognostic Biomarkers of Large Thrombus Burden in Patients with STEMI: A Micro-Computed Tomography Study.血清神经酰胺作为ST段抬高型心肌梗死患者大血栓负荷的预后生物标志物：一项微计算机断层扫描研究
J Pers Med. 2021 Jan 31;11(2):89. doi: 10.3390/jpm11020089.
9
Individualized medicine from prewomb to tomb.从子宫到坟墓的个体化医学。
Cell. 2014 Mar 27;157(1):241-53. doi: 10.1016/j.cell.2014.02.012.
Zotero 插件